Benzyl isothiocyanates BITCs are one of the most extensively studied ITCs with regard to cancer chemoprevention, which was proven to inhibit the phosphorylation activities of three major mitogen-activated protein kinases (MAPKs): ERK1/2, p38, and p-JNK1/2 [50]. The gene discussed is MAPK3; the disease is cancer.